News-Medical.Net on MSN3h
Gilead’s capsid revolution meets our capsid solutions: Sino Biological – Engineering the tools to outsmart HIV
Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...
Immune response may be harnessed to control HIV, primary trial results suggest
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
The New York Times21h
The Learning Network
What are your most lasting memories? How has it shaped your life and the world around you? By Jeremy Engle Have you been paying attention to current events recently? See how many of these 10 ...